BFA
ABBV icon

Bill Few Associates’s AbbVie ABBV Stock Holding History

Bill Few Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.72M Sell
38,621
-3,989
-9% -$858K 2.07% 8
2026
Q1 		$9.27M Buy
42,610
+727
+2% +$161K 2.22% 8
2025
Q4 		$9.57M Buy
41,883
+7,805
+23% +$1.78M 2.35% 7
2025
Q3 		$7.89M Buy
34,078
+349
+1% +$71.1K 2.03% 9
2025
Q2 		$6.26M Sell
33,729
-1,052
-3% -$196K 1.77% 9
2025
Q1 		$7.29M Sell
34,781
-34
-0.1% -$6.61K 2.6% 5
2024
Q4 		$6.19M Buy
34,815
+481
+1% +$88.4K 2.17% 8
2024
Q3 		$6.78M Buy
34,334
+43
+0.1% +$8.03K 2.41% 6
2024
Q2 		$5.88M Sell
34,291
-390
-1% -$64.6K 2.26% 8
2024
Q1 		$6.32M Buy
34,681
+558
+2% +$96.2K 2.56% 5
2023
Q4 		$5.29M Sell
34,123
-396
-1% -$57.7K 2.41% 7
2023
Q3 		$5.15M Buy
34,519
+474
+1% +$69.6K 2.69% 7
2023
Q2 		$4.59M Sell
34,045
-486
-1% -$71.3K 2.37% 10
2023
Q1 		$5.5M Buy
34,531
+465
+1% +$71.1K 3.06% 3
2022
Q4 		$5.51M Sell
34,066
-259
-0.8% -$39.7K 3.25% 4
2022
Q3 		$4.61M Sell
34,325
-2,327
-6% -$334K 3.12% 4
2022
Q2 		$5.61M Sell
36,652
-733
-2% -$112K 3.59% 3
2022
Q1 		$6.06M Buy
37,385
+125
+0.3% +$18.2K 3.3% 3
2021
Q4 		$5.04M Buy
+37,260
New +$4.4M 2.61% 7

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Bill Few Associates's ABBV Position: Q2 2026 in Review

Bill Few Associates reduced its AbbVie (ABBV) stake by 9.4% in Q2 2026, selling an estimated $858K and leaving 38,621 shares worth $9.72M. The position accounts for 2.07% of the portfolio, ranked #8.

Bill Few Associates first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Bill Few Associates held 38,621 shares of AbbVie worth $9.72M as of Q2 2026.
  • Bill Few Associates sold 3,989 AbbVie shares in Q2 2026, an estimated $858K.
  • AbbVie made up 2.07% of Bill Few Associates's portfolio in Q2 2026, its #8 holding.
  • Bill Few Associates first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bill Few Associates's 13F filing for Q2 2026, filed 7 Jul 2026.